Femur Pathological Fracture Caused by Metastatic Bone Disease Derived from Foot Squamous Cell Carcinoma
Article Sidebar
Vol. 1 No. 02 (2017)
April 12, 2017
July 28, 2017
Abstract
Background : Bone is an organ and the most common site that prone to metastatic cancer and cause serious morbidity. Besides, metastatic cancer to bone will limit skeletal function so that decrease quality of life and even death that most of them caused by its complication.
Objective : Reporting a rare case about Squamous Cell Carcinoma that cause femur pathological fracture caused by Metastatic Bone Disease.
Material and Method : Case report in women patients 55 years old with femur close fracture one-third middle caused by Metastatic Bone Disease in RSUD Soetomo Surabaya, period May 2015-March 2016.Data is taken retrospectively from medical record through interview, physical examination, radiological examination, and laboratory.
Result and Discussion : Patients are treated in hospital because of femur close fracture one-third middle caused by Metastatic Bone Disease. Based on physical and radiological examination, it is decided being done by skin traction first. The next plan is surgery. Patients are treated with interlocking nail left femur. Evaluation after surgery is done with medical rehabilitation, that is ROM exercise. Until now, 9 months after surgery, patients still control routinely to be done chemotherapy and there is improvement in patient’s condition.
Conclusion : Metastatic process in bone often cause pathological fracture. Bone Metastatic is common from Breast, Lung, Prostate and Kideney Cancer. There was no publication before about Bone Metastatic Disease come from Squamous Cell Cancer. Mirel’s score is used as guiding in fixation prior to the next treatment. Decision of surgery is considered through patient’s objective and subjective appraisal that can be calculated in Abdurrahman score system.
References
Alimsardjono, Subagjo dkk. 2012. Diktat Anatomi. Surabaya : Departemen Anatomi dan Histologi Fakultas Kedokteran Universitas Airlangga.
Aston.W,Timothy B, Louis S. Tumors.In : Louis S, Selvadurai N, David W, editors Apley’s.
Buga S, dan Sarri JE, The Management of Pain in Metasttic Bone Disese, Cancer Control, 2012, vol 19, No 2, hal 156-166.
Capnna R dan ampanacci DA. 2005. Textbook of bone Metastases. Clinical Features and Prognosis of Bone Metastases.John Wiley and Sons. Wesr Sussex. Hal 65-75 of bone .
Colemen RE, Clinical Features of Metastatic Boe Disease and Risk of Skeletal Morbidity,Clinical Cancer Research, 2006:12:6243s. 135-146.
Cumming D,.Metastatic Disease to Bone: the requirement for improvement for improvement in amultidisciplinary approach, International Ortopaedics (SICOT), 2009:33:493-496.
Farmer ER, Hood AF. Malignant Tumours of the epidermis in oathology of the skin. Cana: Prentice Hall International. 1990: 579-85.
Habib TP. Squamous Cell Carcinoma. Dalam: A colour guide to diagnosis and terapi. St Louis: Mosby.. 1996: 666-8.
Jacofsky DJ, Metastatic Disease to Bone. Hospital Physician,2004:21-28.
Karo WA. Benign & Malignant growth. Dalam: a Lange medical Book ed, Dermatology. Canada: Prentice Hall International. 1991:508-10.
Kelompok kerja kanker FK UI / RSUPNCM. Protokol Larsinoma sel skuamosa kulit. Dalam: Protokol kanker kulit. Jakarta 1995.
Koh HK, Bhawan J. Tumours of the skin. Dalam : Moschella, Hurley, penyunting. Dermatology, 3rded. Philadephia: WB Saunders Co. 1992: 1735-37.
Lipton A, Patophysiologi of Bone Meastases: HowThis Knowledge May Lead to Therapeutic Intervention. Journal of Supportive Oncology,2004;2:205-220.
Mackie RM. Epidermal skin tumours,. Dalam: Rook, Wilkinson, Ebling, penyunting. Textbook of dermatology, 5thed. London: Blackwell Scientific Pub.1993: 1497-1501.
Metastases. Clinical Features and Prognosis of Bone Metastases.John Wiley and Sons. Wesr Sussex. Hal 135-145.
Plunket TA dan Rubens RD.2005. Textbook of bone Metastases. Clinical Features and Prognosis of Bone Metastases.John Wiley and Sons. Wesr Sussex. Hal 65-75.
Rajarubendra N dan Lawrenschuk N. 2010. Bone Cancer Progression and Therapeutic Approaches, Imaging of Bone Metastases. Edisi 1. Elsevier. San Diego, hal: 269-281.
Rata IGAK. Tumor kulit. Dalam: Ilmu Penyakit kulit dan kelamin, edisi ketiga. Jakarta:FKUI. 1999: 207-15.
Roodman,David. 2004. Mechanism of Bone Metastasis. New England Journal Magazine. University of Pittsburg. NEJM 2004;350:1655-64
Schawarth RA, Stoll HL. Squamous cell carcinoma. Dalam: Fitzpatrick TB, Eizen AZ, Wolff K, Freedberg IM, Auten KF, penyunting. Dermatology in general medicine, 4thed, New York: Mc Graw Hill. 1993:821-35.
Schirrmeister H dan Arslandemier C. 2010. Bone Cancer Progression and Therapeutic Approaches, Imaging of Bone Metastases. Edisi 1.Diagnosis of Skeletal Metastases in Malignant Extraskeletal Cancers. Springer. Leipzig. Hal:283-293.
Sloane, E. 1994. Anatomy and Physiology: An Easy Learner. Jones and Bartlett Publisher. Sudbury.
Solomon L.dkk. 2010. Apleys System of Orthopaedics and Fractures, Metastatic Bone Disease,Edisi 9. Hodder Arnold. London, hal 216-218.
System of Orthopaedics and Fractures. Ninth Edition. Boca Raton : Tylor and Francis group, LLC : 2010. P.216-218.
Thompson. 2001. Netter’s Concise Atlas of Orthopaedic Anatomy. Philadelphia : Saunders Elsevier.
Yu HHM,dkk,overview of Diagnosis and Management of Metastati Disease to Bone, Cancer Control ,2012,vil 19, No2, hal : 84-91
Authors
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.
